Second kidney transplant during childhood: clinical aspects, outcomes, and risk factors for graft survival

被引:0
|
作者
Feltran, Luciana de Santis [1 ]
Hamamoto, Fernando Kazuaki [1 ]
Genzani, Camila Penteado [1 ]
Fonseca, Mariana Janiques Barcia Magalhaes [1 ]
de Carvalho, Maria Fernanda Camargo [1 ]
Koch-Nogueira, Paulo Cesar [1 ,2 ]
机构
[1] Hosp Samaritano Sao Paulo, Pediat Kidney Transplantat Dept, Rua Tupi 535 7th Floor, BR-01233001 Sao Paulo, SP, Brazil
[2] Fed Univ Sao Paulo UNIFESP, Pediat Dept, Sao Paulo, Brazil
关键词
Kidney transplantation; Pediatrics; Retransplantation; Clinical aspects; RENAL-TRANSPLANTATION; SMALL CHILDREN; RETRANSPLANTATION; BASILIXIMAB; RECIPIENTS; BENEFIT;
D O I
10.1007/s00467-025-06685-6
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background The demand for kidney retransplants in the pediatric population is increasing as children are receiving their first transplants at a younger age. Methods This retrospective study included 51 children who underwent a second transplantation during childhood. We compared demographic and transplant characteristics, together with the clinical approach at the first and second transplants. Outcomes of second transplants were reported, and factors influencing repeat graft survival were investigated. Results Most of the children were male (69%), with congenital anomalies of the kidney and urinary tract as the primary cause of kidney failure (57%). Fifteen children (39%) weighing 20 kg or less underwent a second transplant. The leading cause of first graft loss was non-immunological (55%), being 27% vascular thrombosis. For the second transplantation, thymoglobulin, tacrolimus, and mycophenolate were preferred, with more frequent indications for anticoagulation prophylaxis. This approach was tailored to a significantly different clinical scenario: only 12% were susceptible to viral infections, and 59% were sensitized (PRA > 50%). After the second transplant, the patient survival rate was 100%, and the second allograft survival rates were 88% and 83% at 1 and 3 years, while after the first transplant, they were 94% and 91%, respectively. The proportional hazard model did not reveal any significant factors influencing the outcomes. Conclusions The clinical and immunological characteristics of children differed significantly between their first and second transplants, necessitating distinct medical approaches. Despite these challenges, pediatric kidney retransplantation seems to have a unique narrative and shows favorable outcomes, with high patient and graft survival rates, representing an effective treatment option.
引用
收藏
页码:2383 / 2391
页数:9
相关论文
共 50 条
  • [21] Incidence of cardiovascular events and associated risk factors in kidney transplant patients: a competing risks survival analysis
    Seoane-Pillado, Maria Teresa
    Pita-Fernandez, Salvador
    Valdes-Canedo, Francisco
    Seijo-Bestilleiro, Rocio
    Pertega-Diaz, Sonia
    Fernandez-Rivera, Constantino
    Alonso-Hernandez, Angel
    Gonzalez-Martin, Cristina
    Balboa-Barreiro, Vanesa
    BMC CARDIOVASCULAR DISORDERS, 2017, 17
  • [22] Risk factors for development of rejection in kidney transplant patients
    Ergin, Mustafa
    Oguz, Ebru Gok
    Yayar, Ozlem
    Atilgan, Kadir Gokhan
    Oztekin, Sanem
    Ayli, Mehmet Deniz
    CUKUROVA MEDICAL JOURNAL, 2020, 45 (01): : 215 - 222
  • [23] Prominent Impact of Community Risk Factors on Kidney Transplant Candidate Processes and Outcomes
    Schold, J. D.
    Heaphy, E. L. G.
    Buccini, L. D.
    Poggio, E. D.
    Srinivas, T. R.
    Goldfarb, D. A.
    Flechner, S. M.
    Rodrigue, J. R.
    Thornton, J. D.
    Sehgal, A. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (09) : 2374 - 2383
  • [24] Risk factors and outcomes for delayed kidney graft function in simultaneous heart and kidney transplant recipients: A UNOS/OPTN database analysis
    Parajuli, Sandesh
    Karim, Aos. S.
    Muth, Brenda L.
    Leverson, Glen. E.
    Yang, Qiuyu
    Dhingra, Ravi
    Smith, Jason W.
    Foley, David P.
    Mandelbrot, Didier A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (09) : 3005 - 3013
  • [25] Neutropenia in kidney and liver transplant recipients: Risk factors and outcomes
    Mavrakanas, Thomas A.
    Fournier, Marie-Andree
    Clairoux, Sarah
    Amiel, Jacques-Alexandre
    Tremblay, Marie-Eve
    Vinh, Donald C.
    Coursol, Christian
    Thirion, Daniel J. G.
    Cantarovich, Marcelo
    CLINICAL TRANSPLANTATION, 2017, 31 (10)
  • [26] Long-Term Kidney Transplant Graft Survival: Single-Center Experience
    Ismayilov, Hikmet
    Hasanova, Zemfira
    Huseynov, Khanbaba
    Babayev, Fariz
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2024, 22 (01) : 263 - 264
  • [27] The effect of the I/D polymorphism of the angiotensin-converting enzyme gene on the cardiovascular risk and graft survival of kidney transplant patients
    Fedor Roland
    Kovacs David Agoston
    Locsey Lajos
    Fagyas Miklos
    Asztalos Laszlo
    Toth Attila
    ORVOSI HETILAP, 2016, 157 (24) : 938 - 945
  • [28] Does graft mass impact on pediatric kidney transplant outcomes?
    Feltran, Luciana de Santis
    Koch Nogueira, Paulo Cesar
    Ajzen, Sergio Aron
    Yuji Verrastro, Carlos Gustavo
    Pacheco-Silva, Alvaro
    PEDIATRIC NEPHROLOGY, 2014, 29 (02) : 297 - 304
  • [29] Post-transplant lymphoproliferative disease may be an adverse risk factor for patient survival but not graft loss in kidney transplant recipients
    Francis, Anna
    Johnson, David W.
    Craig, Jonathan
    Teixeira-Pinto, Armando
    Wong, Germaine
    KIDNEY INTERNATIONAL, 2018, 94 (04) : 809 - 817
  • [30] Risk Factors for Retransplant Kidney Recipients: Relisting and Outcomes From Patients' Primary Transplant
    Heaphy, E. L. G.
    Poggio, E. D.
    Flechner, S. M.
    Goldfarb, D. A.
    Askar, M.
    Fatica, R.
    Srinivas, T. R.
    Schold, J. D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (06) : 1356 - 1367